<?xml version="1.0" encoding="UTF-8"?>
<p>Currently, one of the most serious challenges of the pharmaceutical industry is the emergence of antimicrobial resistance, which is considered by World Health Organization (WHO) as one of the top ten global challenges [
 <xref rid="B2-antibiotics-09-00428" ref-type="bibr">2</xref>]. Moreover, the adverse effects of currently used therapeutic agents (dysbiosis, hepato- and nephrotoxicity, and hypersensitivity reactions) has led to an increased interest in the discovery of new, natural compounds with anti-infectious and immunomodulatory activity.
</p>
